Met Life Investment Management, LLC Chemo Centryx, Inc. Transaction History

Met Life Investment Management, LLC

  • $17.1 Billion
  • Q3 2024

Shares

44 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

May 10, 2024
BUY
$22.17 - $51.8 $11,506 - $26,884
519 Added 1.59%
33,135 $1.71 Million
Q3 2022

Jun 14, 2023
BUY
$22.17 - $51.8 $734,602 - $1.72 Million
33,135 New
33,135 $1.71 Million
Q3 2022

Mar 22, 2023
BUY
$22.17 - $51.8 $11,506 - $26,884
519 Added 1.59%
33,135 $1.71 Million
Q3 2022

Nov 14, 2022
BUY
$22.17 - $51.8 $11,506 - $26,884
519 Added 1.59%
33,135 $1.71 Million
Q2 2022

May 10, 2024
BUY
$15.36 - $27.51 $32,194 - $57,660
2,096 Added 6.87%
32,616 $808,000
Q2 2022

Jun 20, 2023
BUY
$15.36 - $27.51 $500,981 - $897,266
32,616 New
32,616 $808,000
Q2 2022

Mar 22, 2023
BUY
$15.36 - $27.51 $32,194 - $57,660
2,096 Added 6.87%
32,616 $808,000
Q2 2022

Aug 11, 2022
BUY
$15.36 - $27.51 $32,194 - $57,660
2,096 Added 6.87%
32,616 $808,000
Q1 2022

May 10, 2024
BUY
$22.22 - $39.12 $678,154 - $1.19 Million
30,520 New
30,520 $765,000
Q1 2022

Jun 20, 2023
BUY
$22.22 - $39.12 $678,154 - $1.19 Million
30,520 New
30,520 $765,000
Q1 2022

Mar 22, 2023
BUY
$22.22 - $39.12 $251,774 - $443,268
11,331 Added 59.05%
30,520 $765,000
Q1 2022

May 12, 2022
BUY
$22.22 - $39.12 $251,774 - $443,268
11,331 Added 59.05%
30,520 $765,000
Q4 2021

Jun 21, 2023
BUY
$18.38 - $40.5 $352,693 - $777,154
19,189 New
19,189 $698,000
Q3 2021

Jun 21, 2023
BUY
$13.18 - $19.83 $252,911 - $380,517
19,189 New
19,189 $328,000
Q2 2021

Jun 21, 2023
BUY
$9.59 - $50.88 $184,022 - $976,336
19,189 New
19,189 $256,000
Q1 2021

May 17, 2024
BUY
$49.53 - $68.4 $950,431 - $1.31 Million
19,189 New
19,189 $983,000
Q1 2021

Jun 26, 2023
BUY
$49.53 - $68.4 $950,431 - $1.31 Million
19,189 New
19,189 $983 Million
Q1 2021

Mar 22, 2023
SELL
$49.53 - $68.4 $87,321 - $120,589
-1,763 Reduced 8.41%
19,189 $983,000
Q1 2021

May 14, 2021
SELL
$49.53 - $68.4 $87,321 - $120,589
-1,763 Reduced 8.41%
19,189 $983,000
Q4 2020

Jun 22, 2023
BUY
$47.25 - $65.16 $989,982 - $1.37 Million
20,952 New
20,952 $1.3 Million
Q3 2020

May 24, 2024
BUY
$46.35 - $61.69 $57,752 - $76,865
1,246 Added 6.32%
20,952 $1.15 Billion
Q3 2020

Jun 26, 2023
BUY
$46.35 - $61.69 $971,125 - $1.29 Million
20,952 New
20,952 $1.15 Million
Q3 2020

Mar 22, 2023
BUY
$46.35 - $61.69 $57,752 - $76,865
1,246 Added 6.32%
20,952 $1.15 Million
Q3 2020

Nov 13, 2020
BUY
$46.35 - $61.69 $57,752 - $76,865
1,246 Added 6.32%
20,952 $1.15 Million
Q2 2020

May 24, 2024
BUY
$38.58 - $65.07 $760,257 - $1.28 Million
19,706 New
19,706 $1.13 Billion
Q2 2020

Jun 26, 2023
BUY
$38.58 - $65.07 $760,257 - $1.28 Million
19,706 New
19,706 $1.13 Million
Q2 2020

Mar 22, 2023
BUY
$38.58 - $65.07 $70,447 - $118,817
1,826 Added 10.21%
19,706 $1.13 Million
Q2 2020

Aug 14, 2020
BUY
$38.58 - $65.07 $70,447 - $118,817
1,826 Added 10.21%
19,706 $1.13 Million
Q1 2020

Jul 12, 2023
BUY
$32.73 - $50.78 $585,212 - $907,946
17,880 New
17,880 $718,000
Q4 2019

Jul 12, 2023
BUY
$6.81 - $39.55 $121,762 - $707,154
17,880 New
17,880 $707,000
Q4 2019

Mar 22, 2023
SELL
$6.81 - $39.55 $19,245 - $111,768
-2,826 Reduced 13.65%
17,880 $707,000
Q4 2019

Feb 14, 2020
SELL
$6.81 - $39.55 $19,245 - $111,768
-2,826 Reduced 13.65%
17,880 $707,000
Q3 2019

Jul 12, 2023
BUY
$6.47 - $8.96 $133,967 - $185,525
20,706 New
20,706 $140,000
Q3 2019

Mar 22, 2023
BUY
$6.47 - $8.96 $53,791 - $74,493
8,314 Added 67.09%
20,706 $140,000
Q3 2019

Nov 14, 2019
BUY
$6.47 - $8.96 $53,791 - $74,493
8,314 Added 67.09%
20,706 $140,000
Q2 2019

Jul 12, 2023
BUY
$8.31 - $14.85 $172,066 - $307,484
20,706 New
20,706 $192,000
Q1 2019

Jul 13, 2023
BUY
$10.01 - $13.89 $124,043 - $172,124
12,392 New
12,392 $172,000
Q4 2018

Jul 13, 2023
BUY
$9.15 - $12.26 $113,386 - $151,925
12,392 New
12,392 $135,000
Q4 2018

Mar 22, 2023
SELL
$9.15 - $12.26 $62,595 - $83,870
-6,841 Reduced 35.57%
12,392 $135,000
Q4 2018

Feb 14, 2019
SELL
$9.15 - $12.26 $62,595 - $83,870
-6,841 Reduced 35.57%
12,392 $135,000
Q3 2018

Jul 13, 2023
BUY
$10.49 - $13.72 $129,992 - $170,018
12,392 New
12,392 $156,000
Q3 2018

Mar 22, 2023
BUY
$10.49 - $13.72 $201,754 - $263,876
19,233 New
19,233 $243,000
Q3 2018

Nov 14, 2018
BUY
$10.49 - $13.72 $71,762 - $93,858
6,841 Added 55.2%
19,233 $243,000
Q1 2018

May 15, 2018
BUY
$5.9 - $14.99 $73,112 - $185,756
12,392 New
12,392 $169,000

Others Institutions Holding CCXI

# of Institutions
6
Shares Held
66.3K
Call Options Held
0
Put Options Held
0
View Full List

About ChemoCentryx, Inc.

CCXI Quotes by TradingView
  • Ticker CCXI
  • Exchange NASDAQ
  • Shares Outstandng 71,919,696
  • Market Cap $3.68M
  • Description
  • ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...
More about CCXI
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email